Post-operative lymphocyte count may predict the outcome of radical resection for gallbladder carcinoma

Anticancer Research

Volumn 33, Issue 8, 2013, Pages 3439-3444

  Iwase, Ryota ^a   Shiba, Hiroaki ^a   Haruki, Koichiro ^a   Fujiwara, Yuki ^a   Furukawa, Kenei ^a   Futagawa, Yasuro ^a   Wakiyama, Shigeki ^a   Misawa, Takeyuki ^a   Yanaga, Katsuhiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gallbladder carcinoma; Lymphocyte count; Operation; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GALLBLADDER CARCINOMA; HUMAN; LYMPHOCYTE COUNT; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADICAL RESECTION;

GALLBLADDER CARCINOMA; LYMPHOCYTE COUNT; OPERATION; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; POSTOPERATIVE CARE; TREATMENT OUTCOME;

EID: 84883282750     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Zhu AX, Hong TS, Hezel AF and Kooby DA: Current management of gallbladder carcinoma. Oncologist 15: 168-181, 2010.
2. Chijiiwa K, Kai M, Nagano M, Hiyoshi M, Ohuchida J and Kondo K: Outcome of radical surgery for stage IV gallbladder carcinoma. J Hepatobiliary Pancreat Surg 14: 345-350, 2007.
3. Nagakawa T, Kayahara M, Ikeda S, Futakawa S, Kakita A, Kawarada H, Matsuno M, Takada T, Takasaki K, Tanimura H, Tashiro S and Yamaoka Y: Biliary tract cancer treatment: Results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg 9: 569-575, 2002.
4. Toyonaga T, Chijiiwa K, Nakano K, Noshiro H, Yamaguchi K, Sada M, Terasaka R, Konomi K, Nishikata F and Tanaka M: Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinoma. World J Surg 27: 266-271, 2003.
5. Kokudo N, Makuuchi M, Natori T, Sakamoto Y, Yamamoto J, Seki M, Noie T, Sugawara Y, Imamura H, Asahara S and Ikari T: Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg 138: 741-750, 2003.
6. Frena A, Guardia G and Martin F: Outcome of radical surgery for carcinoma of the gallbladder according to the tumor node matastasis and Japanese Society of Biliary Surgery stages. J Gastrointest Surg 8: 580-590, 2004.
7. Kayahara M and Nagakawa T: Recent trends of gallbladder cancer in Japan: An analysis of 4,770 patients. Cancer 110: 572-580, 2007.
8. Puhalla H, Wild T, Bareck E, Pokorny H, Ploner M, Soliman T, Stremitzer S, Depisch D, Laengle F and Gruenberger T: Longterm follow-up of surgically treated gallbladder cancer patients. Eur J Surg Oncol 28: 857-863, 2002.
9. Bishara S, Griffin M, Cargill A, Bali A, Gore ME, Kaye SB, Shepherd JH and Van Trappen PO: Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer. Eur J Obstet Gynecol Reprod Biol 138: 71-75, 2008.
10. Chen MH, Chang PM, Chen PM, Tzeng CH, Chu PY, Chang SY and Yang MH: Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. J Cancer Res Clin Oncol 135: 1783-1790, 2009.
11. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ and Lodge JP: Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 34: 55-60, 2008.
12. Ong SL, Garcea G, Thomasset SC, Neal CP, Lloyd DM, Berry DP and Dennison AR: Ten-year experience in the management of gallbladder cancer from a single hepatobiliary and pancreatic centre with review of the literature. HPB 10: 446-458, 2008.
13. Fujiwara Y, Shiba H, Furukawa K, Iida T, Sakamoto T, Gocho T, Wakiyama S, Hirohara S, Ishida Y, Misawa T, Ohashi T and Yanaga K: Perioperative change in white blood cell count predicts outcome of hepatic resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 17: 892-897, 2010.
14. Haruki K, Shiba H, Fujiwara Y, Furukawa K, Wakiyama S, Ogawa M, Ishida Y, Misawa T and Yanaga K: Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection. J Surg Oncol 106: 31-35, 2012.
15. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P and Van Pel A: Tumor antigens recognized by T-lymphocytes. Annu Rev Immunol 12: 337-365, 1994.
16. Brandle D, Brasseur F, Weynants P, Boon T and Van den Eynde B: A mutated HLA-A2 molecule recognized by autologous cytotoxic T-lymphocytes on a human renal cell carcinoma. J Exp Med 183: 2501-2508, 1996.
17. Tanaka F, Abe M, Akiyoshi T, Nomura T, Sugimachi K, Kishimoto T, Suzuki T and Okada M: The anti-human tumor effect and generation of human cytotoxic T-cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the interleukin-6 gene using adenovirus vector. Cancer Res 57: 1335-1343, 1997.
18. Sobin LH, Wittekind C: TNM classification of Malignant Tumors (6th edition). International Union Against Cancer, 2002.
19. De Giorgi U, Mego M, Scarpi E, Giuliano M, Giordano A, Reuben JM, Valero V, Ueno NT, Hortobagyi GN and Cristofanilli M: Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer. Clin Breast Cancer 12: 264-269, 2012.
20. Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Tominaga M, Okunaga R, Shibata K, Ohta M and Kitano S: Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resection. J Gastrointest Surg 11: 596-602, 2007.
21. Han HS, Cho JY, Yoon YS, Ahn KS and Kim H: Preoperative inflammation is a prognostic factor for gallbladder carcinoma. Br J Surg 98: 111-116, 2011.
22. Sakata J, Shirai Y, Wakai T, Ajioka Y and Hatakeyama K: Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma. Ann Surg Oncol 17: 1831-1840, 2010.
23. Yamaguchi R, Nagino M, Oda K, Kamiya J, Uesaka K and Nimura Y: Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg 89: 1130-1136, 2002.
24. Kayahara M, Nagakawa T, Nakagawara H, Kitagawa H and Ohta T: Prognostic factors for gallbladder cancer in Japan. Ann Surg 248: 807-814, 2008.
25. Shi JS, Zhou LS, Han Y, Zhu AJ, Sun XJ and Yang YJ: Expression of tumor necrosis factor and its receptor in gallstone and gallbladder carcinoma tissue. Hepatobiliary Pancreat Dis Int 3: 448-452, 2004.
26. Sun XJ, Shi JS, Han Y, Wang JS and Ren H: Diagnosis and treatment of polypoid lesions of the gallbladder: Report of 194 cases. Hepatobiliary Pancreat Dis Int 3: 591-594, 2004.
27. Wortzel RD, Philipps C and Schreiber H: Multiple tumourspecific antigens expressed on a single tumour cell. Nature 304: 165-167, 1983.
28. Van den Eynde B, Hainaut P, Herin M, Knuth A, Lemoine C, Weynants P, van der Bruggen P, Fauchet R and Boon T: Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 44: 634-640, 1989.
29. Larsson M, Fonteneau JF and Bhardwaj N: Dendritic cells resurrect antigens from dead cells. Trends Immunol 22: 141-148, 2001.
30. Wang RF: The role of MHC class II-restricted tumor antigens and CD4+ T-cells in antitumor immunity. Trends Immunol 22: 269-276, 2001.
31. Marzo AL, Kinnear BF, Lake RA, Frelinger JJ, Collins EJ, Robinson BW and Scott B: Tumor-specific CD4+ T-cells have a major "post-licensing" role in CTL mediated antitumor immunity. J Immunol 165: 6047-6055, 2000.
32. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP and Gabrilovich DI: Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6: 1755-1766, 2000.
33. Nakakubo Y, Miyamoto M, Cho Y, Hida Y, Oshikiri T, Suzuoki M, Hiraoka K, Itoh T, Kondo S and Katoh H: Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer 89: 1736-1742, 2003.
34. Sugita S, Sasaki A, Iwaki K, Uchida H, Kai S, Shibata K, Ohta M and Kitano S: Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: A retrospective study. Eur J Surg Oncol 34: 339-345, 2008.
35. Dietz A, Heimlich F, Daniel V, Polarz H, Weidauer H and Maier H: Immunomodulating effects of surgical intervention in tumors of the head and neck. Otolaryngol Head Neck Surg 123: 132-139, 2000.
36. Klein HG: Immunomodulatory aspects of transfusion: A once and future risk? Anesthesiology 91: 861-865, 1999.